Merck KGaA : The downward trend should continue
Entry price | Target | Stop-loss | Potential |
---|
€98.7 |
€95.09 |
€102.7 |
+3.66% |
---|
As it is firmly anchored in an underlying downward trend, stocks in Merck KGaA should not see any recovery over the coming trading sessions.
Strengths● The group's activity appears highly profitable thanks to its outperforming net margins.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● The group shows a rather high level of debt in proportion to its EBITDA.
● The company's enterprise value to sales, at 3.38 times its current sales, is high.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.